|
Volumn 229, Issue 1, 1992, Pages 63-67
|
Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-α-induced hepatitis in mice
a a a a a a a
a
EISAI CO LTD
(Japan)
|
Author keywords
E3330; Galactosamine; Leukotrienes; Liver injury; Prostanoids; TNF (tumor necrosis factor )
|
Indexed keywords
6 HYDROXY 4,5,7 TRIMETHYL 2 (4 SULFAMOYLBENZYLAMINO)BENZOTHIAZOLE;
E 3330;
GALACTOSAMINE;
INDOMETACIN;
LEUKOTRIENE B4;
LIPOXYGENASE INHIBITOR;
LIVER PROTECTIVE AGENT;
PROSTAGLANDIN E2;
QUINONE DERIVATIVE;
RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;
THROMBOXANE B2;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
HEPATITIS;
ICOSANOID METABOLISM;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER INJURY;
LIVER PROTECTION;
MALE;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PERITONEUM CELL;
PRIORITY JOURNAL;
RAT;
ANIMAL;
ASCITIC FLUID;
BENZOQUINONES;
DINOPROSTONE;
GALACTOSAMINE;
HEPATITIS, TOXIC;
IN VITRO;
LEUKOTRIENE B4;
MALE;
MICE;
MICE, INBRED C3H;
PROPIONIC ACIDS;
RATS;
THROMBOXANE B2;
TUMOR NECROSIS FACTOR;
|
EID: 0026545695
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/0014-2999(92)90286-D Document Type: Article |
Times cited : (11)
|
References (18)
|